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ABSTRACT 
 
 
 
 When treated with interferon β-1b, gene NCOA7 expresses a new variant that 
begins from an alternative start site NCAO7-AS with strong antioxidant properties. 
Segments of three different lengths of the upstream region of the gene were inserted into 
phRLnull. After testing and confirming their structure, the plasmids were transfected into 
mammalian cells. A luciferase assay was performed to determine which segments showed 
an increase in activity when treated with interferon. While each ligated plasmid acted as a 
strong promoter for Renilla luciferase, no significant difference in signal due to INFβ-1b 
treatment was observed.  
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BACKGROUND 
 
 
 
Reactive Oxygen Species  
 Damage to cellular components at a molecular level can occur in a number of 
ways. A common form of damage that occurs to biomolecules, such as nucleic acids, 
proteins, and lipids is oxidative damage, resulting from reactive oxygen species (ROS). 
ROS are partially reduced species of molecular oxygen that are formed as byproducts of 
metabolic reactions that occur naturally within cells (Imlay, 2003). ROS include 
superoxide (O2
-
), hydrogen peroxide (H2O2), and hydroxide radicals (OH
.
) as seen in 
Figure 1 below.  
 
Figure 1: The Process of Reducing of Molecular Oxygen to Water. ROS molecules are 
generated at each internal step (Imlay, 2003).  
 
ROS have a greater chance of causing injury to an organism than molecular 
oxygen due to being greater electron acceptors, thus making them better oxidants (Imlay, 
2003). Of the three ROS mentioned the hydroxyl radical is the most reactive, and will 
react with the first molecule it encounters (Imlay, 2003). The other two are less reactive 
due to hydrogen peroxide’s stable O-O bond and superoxide’s negative charge preventing 
it from interacting with other negatively charged molecules (Imlay, 2003).  
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Formation of Superoxide and Hydrogen Peroxide 
 Studies have revealed that superoxide and hydrogen peroxide are produced in the 
mitochondria of a cell in physiological conditions at the NADH dehydrogenase in the 
electron transport chain (for review see Turrens, 2004). At this location ROS are 
generated at the NADH binding site by a reduced flavin molecule when the radical is 
passed from the reduced flavin molecule to molecular oxygen instead of the Q-site of the 
enzyme, as per usual function as seen in Figure 2 (Esterházy et al., 2008). It has also 
been shown that several other flavin molecules as well as succinate dehydrogenase and 
fumarate dehydrogenase also can generate ROS in this was (Imlay, 2003).  
 
Figure 2: The Electron Transport Chain’s Complex I (NADH Dehydrogenase.) Reactive 
oxygen species are generated from reduced flavin molecule giving electrons to molecular oxygen. 
Normal pathway in blue, ROS generating pathway in red (Esterházy et al., 2008). 
 
Hydroxyl Radical Formation  
 Hydroxyl radicals can be generated in a few different processes. The primary way 
that hydroxyl radicals are formed is through Fenton chemistry (Tashjian, 2009). Ferrous 
iron ions can react with hydrogen peroxide to generate ferric iron, a hydroxyl ion, and a 
hydroxyl radical. The reaction must be carried out with free iron generated by reducing 
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ferric iron (Fe
3+
) to ferrous ion (Fe
2+
) (Imlay, 2003). Molecules such as superoxide, 
cysteine, and FADH2 can accomplish the reduction of Fe
3+
 to Fe
2+
 (Imlay, 2003).  
 
Cellular Damage by ROS 
 As each of the reactive oxygen species have unique structures and levels of 
stability each species creates different types of damage in the cell. As stated before, the 
hydroxyl radical is the most dangerous of the ROS species as it will react with the first 
molecule it encounters (Imlay, 2003). As such the hydroxyl radical can create a large 
amount of damage in the cell. The most notable areas hydroxyl radicals can affect are the 
lipid membrane and nucleic acids (Tashjian, 2009). When hydroxyl radicals interact with 
the methylene groups between the cis double bonds of polyunsaturated acids in the cell 
membrane, carbon centered radicals are formed (Marnett, 1999).  
 The production of the carbon centered radicals can create a chain reaction of lipid 
peroxidation from a single hydroxyl radical creating vast damage to the membrane 
(Tashjian, 2009). Along with damage to the membrane, lipid peroxidation creates 
products that are hazardous to the cell. For instance, the product 4-hydroxynenal (HNE) 
has the ability to modify cysteine, lysine, and histidine residues which can lead to vital 
proteins becoming inactive, and could eventually lead to disruptions in DNA, protein 
synthesis, and gene regulation (Tashjian, 2009).  Another dangerous product is 
Malondialdehyde which interacts with DNA to cause G to T transitions, as well as C to T 
and A to G transversions less frequently (Marnett, 1999).      
  As superoxide and hydrogen peroxide are less reactive than hydroxyl radicals, 
they are less dangerous to the cell and primarily are hazardous for their parts in creating 
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hydroxyl radicals (see formation of Hydroxyl radicals). Superoxide has the ability to 
react with iron-sulfur clusters causing them to be inactivated by binding to ferrous iron in 
the enzyme’s active site to form a reduced ferrous ion and hydrogen peroxide which then 
creates a hydroxyl radical (Tashjian, 2009).  
 Hydrogen peroxide causes damage to the cell by oxidizing methionine residues, 
cysteine residues, ferric iron, and iron sulfur clusters (Imlay, 2003).  When the sulfur 
atoms within cysteine clusters are oxidized by hydrogen peroxide disulfide bridges can be 
formed within the protein.  This alteration can cause cysteine residues to lose catalytic 
activity and severely alter protein structure, possibly leaving them inert (Tashjian, 2009).  
 Damage to DNA is the most damaging effect caused by ROS. By oxidizing 
nucleotides, transversions and frameshift mutations can occur in the cell and create 
truncated proteins, create premature transcription stops for essential proteins, changes in 
the cell cycle, or changes in gene regulation. Such effects can lead to a variety of negative 
health effects leading to oxidative stress and damage being linked to such detrimental 
effects and conditions such as aging, cancer, muscular dystrophy, Alzheimer’s, 
Parkinson’s, ALS, and many other forms of human pathogenesis (Tashjian, 2009; Yu et 
al., submitted for publication). 
 
Oxidative Damage Prevention 
 Because some of the enzymes that create ROS within the body are vital, such as 
NADH dehydrogenase, mechanisms are set in place by the cell to limit ROS formation or 
limit damage by previously formed ROS. The most common mechanism is the use of 
antioxidant enzymes which have the ability to convert ROS into oxygen and water 
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molecules (Tashjian, 2009). These enzymes such as superoxide dismutase, catalase, and 
Selenium-dependent GSH peroxidase only work on superoxide and hydrogen peroxide 
and do not affect hydroxyl radicals (Tashjian, 2009).  
 
Oxidative Resistance Genes 
In addition to antioxidant proteins, eukaryotic cells are equipped with genes that 
allow for the translation of a family of oxidative resistance proteins. These are called the 
OXR family of genes due to homologous structures within each of the genes.  Currently 
the mechanism of how the OXR family proteins prevent oxidative damage is not fully 
understood, but studies have shown that the expression of these proteins can protect cells 
from oxidative damage (Elliot & Volkert, 2004; Volkert et al., 2000; Yu et al., submitted 
for publication).  
 
OXR1 
 One of the genes within the OXR gene family is OXR1. The OXR1 gene was 
discovered in a screen devised to identify human genes that confer resistance to oxidative 
damage to a repair-defective spontaneous mutator strain of E. coli and was selected as a 
gene of particular interest (Volkert, et al., 2000). This strain of bacteria has mutant mutM 
and mutY genes causing the bacteria to develop a synergistic increase in GC→TA 
transversion mutagenesis as the bacterial cells needs these genes to correct damage from 
the predominant DNA oxidative lesion 8-oxoguanine (8-oxoG). Buildup of 8-oxoG will 
result in GC→TA transversions and the amount of DNA oxidative DNA occurring within 
the cell can be monitored by the lacZ cc104 allele. This allele reverts to Lac+ and a blue 
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product only in the presence of GC→TA transversions such as those caused by buildup 
of 8-oxoG in this bacterial strain. Cells naturally produce ROS which cause buildup of 8-
oxoG as part of their natural metabolism to generate the necessary mutations to turn 
colonies blue through activation of the LacZ gene. When the human OXR1 gene was 
inserted into this bacterial strain, the gene suppressed oxidative DNA damage to the cells, 
indicated by the colonies turning blue at a lower rate than control cells without the OXR1 
gene, suggesting that the gene conferred oxidative resistance (Volkert, et al., 2000).   
Further study revealed that yeast deficient in OXR1 are more vulnerable to 
damage by hydrogen peroxide, showing that the protein helps to prevent damage done by 
oxidative stress (Volkert, et al., 2000). Oxidative resistance was shown to be restored by 
expressing the human OXR1 gene in the yeast OXR1 deletion mutant, suggesting the 
oxidation resistance function is also functional in the human protein (Volkert, et al., 
2000).   
Later study revealed that OXR1 can be induced by both heat and oxidative stress and is 
localized to mitochondria within yeast and humans (Elliot & Volkert, 2004).  This 
localization is most likely due to the large amount of reactive oxygen species that is 
created by the metabolic processes of the mitochondria.  
 Homologues of the OXR1 gene were found within many species of Eukaryotes 
but not in Prokaryotes. The most conserved region between OXR1 homologues is the 
carboxyl-terminal half of the protein which may help give the protein its oxidative 
damage resistance properties (Volkert, et al., 2000).  
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NCOA7 
 Another gene within the oxidative resistance gene family is the gene nuclear 
receptor coactivator protein 7 (NCOA7). NCOA7 is a very close homologue to the OXR1 
gene, as seen in Figure 3. This close homology between genes was likely as a result of a 
duplication event (Durand et al., 2007). Study of NCOA7 in a repair-defective 
spontaneous mutator strain of E. coli showed that the addition of the human NCOA7 
gene was sufficient to lower rates of spontaneous oxidative mutations. Unlike the OXR1 
protein however, the NCOA7 protein is localized to the nucleus and cytoplasm, but is 
stimulated to migrate to the nucleus when cells are treated with estradiol, as NCOA7 is an 
estrogen receptor associated protein (Durand et al., 2007).  
 
Figure 3: Comparison of OXR1 and NCOA7 Structure. Exon and intron structures of both 
genes are shown. Black boxes are exons that comprise the minimal OXR domain, grey boxes are 
areas of similarity between the two genes, and white boxes are regions that are unique to either 
gene. The striped exons are exons 10 and 11, which are also unique to OXR1. The length of the 
lines connecting exons is an indication of the relative size of the intron (Durand et al., 2007).  
 
 While OXR1 is induced to be expressed during oxidative stress, NCOA7 is 
expressed constitutively within the cell. This expression pattern along with NCOA7’s 
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different localization and its estrogen stimulated association with the estrogen receptor 
suggest that NCOA7 may serve to prevent a different cellular function of oxidative 
damage protection than OXR1, likely oxidative by-products of estrogen metabolite-
mediated DNA damage (Durand et al., 2007).  
 Structurally NCOA7 differs from OXR1 in that it does not contain any 
homologous exons to exons 10 and 11 of OXR1. Each gene also contains exons that are 
unique in upstream region of the minimal OXR domain. The minimal OXR domain is a 
conserved region of the OXR1 and NCOA7 proteins that has been shown, using truncated 
proteins, to be required to confer antioxidant activity (Durand et al., 2007).    
 
NCOA7-AS 
 Analysis of peripheral blood mononuclear cells gathered from muscular 
dystrophy patients and human fetal brain cells led to the discovery of an alternative start 
variant of NCOA7 known as NCOA7-AS. NCOA7-AS differs from the full length 
protein as its transcription begins at an alternate start intron, intron 10a, which is not 
included within the full length protein as seen in Figure 4. By spicing so, the NCOA7-
AS protein does not contain NCOA7 exon 9. This exon, a part of the minimal OXR 
domain, is considered essential for oxidative damage resistance activity in full length 
NCOA7, however the NCOA7-AS protein has shown to confer oxidative damage 
resistance comparable to the full length protein (Yu et al., submitted for publication). 
NCOA7-AS does contain NCOA7’s C-terminal TLDc domain, the last five exons of 
NCOA7, making it a member of the OXR family (Yu et al., submitted for publication).  
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Figure 4: Comparison of the Structures of the NCOA7, NCOA7-AS, and OXR1 Genes (Yu et 
al., submitted for publication) 
  
Unlike NCOA7, NCOA7-AS is not produced constitutively within the cells and 
instead transcription is induced by the compound interferonβ-1b (INF), a drug commonly 
used to treat the relapsing-remitting form of the autoimmune disease muscular sclerosis 
(MS). The exact role of NCOA7-AS in the treatment of MS is not confirmed, but it likely 
that tissue inflammation seen in MS could be caused by an increase of local ROS. Thus 
activation of the NCOA7-AS production by INF, long associated for its ability to reduce 
inflammation, may also reduce oxidative damage and lower the rate of neuronal cell body 
loss (Yu et al., submitted for publication).   
 
Gene Induction by Interferon  
The induction of genes such as NCOA7-AS by INF involves an interaction of the 
compound with two cell surface receptor chains known as interferon alpha receptor 
1(INFAR1) and interferon alpha receptor 2 (INFAR2). Once IFN has bound to the cell 
receptors, they phosphorylate themselves using specific tyrosine amino acid residues 
which lie within the cytoplasmic domain of each of the receptor chains. The receptor 
chains then activate a signaling pathway by phosphorylating Janus Kinase 1(JAK1) and 
 14 
Tyrosine Kinase 2 (Tyk2) which then phosphorylates the Signal Transducers and 
Activators of Transcription (STATs), known as STAT1 and STAT2, which bind with 
Interferon Response Factor 9 (INF9) as a complex of several proteins to response 
elements in the gene’s promoter region. Such elements include the STAT response 
element, interferon-stimulated response elements (ISRE), and the IRF site (Stark and 
Darnell, 2012; Stark et al., 1998).  
Experiments were done in HT1080 cells where the JAK1, STAT2, or the IFNAR1 
receptor genes were inactive in order to determine if the JAK-STAT signaling pathway 
was necessary for the production of NCOA7-AS protein. Each mutation eliminated the 
ability of INF to induce NCOA7-AS production, confirming the JAK-STAT pathway was 
necessary for INF induction of NCOA7-AS (Yu et al., submitted for publication).  
 
NCOA7-AS Promoter Region 
 NCOA7-AS was identified as an interferon induced gene. Examination of the 
DNA sequence upstream of exon 10a identifies a possible promoter region of NCOA7-
AS (Figure 5). This region contains a sequence which is very close to that of two other 
INF inducible genes known as OAS1a and OAS1b.  Within this homologous region lay 
the STAT, ISRE, and IRF regions which are suspected as being the essential elements 
needed for NCOA7-AS induction by INF (Yu et al., submitted for publication).    
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Figure 5: Comparison of the NCOA7-AS Promoter Region to INF Inducible Genes OAS1 
and OAS2 (Yu et al., submitted for publication). 
 
 
While it is known that the JAK-STAT signaling pathway is necessary for INF 
induction of NCOA7-AS production, the exact portion of the upstream regulatory area of 
the gene needed for induction has not been verified. As such it is currently unknown 
whether or not induction can be carried out with only the promoter region elements 
shown above, or if activator or enhancer sequences upstream are involved in induction in 
some way as well. A possible way of determining what portion of the promoter region is 
necessary for INF induction is use of the Dual-Glo® luciferase Assay System, after 
fusion of predicted promoter sequences to a promoter-less luciferase coding sequence.  
 
Dual-Glo® Luciferase Assay System 
 The Dual-Glo® Luciferase Assay System is a product of the company Promega 
that is used to perform high throughput analysis of mammalian cells that contain genes 
for both firefly and Renilla luciferase within a 96- or 384-well plate format (Promega, 
2013). The assay works by using one type of luciferase as a transfection control and 
comparing the expression of the experimental luciferase to the expression of control 
(Promega, 2013).   
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 The assay makes use of two substrates, each used to activate expression of one 
type of luciferase creating luminescence which can be read by a plate reader. The first 
substrate, the Dual-Glo® Luciferase substrate, causes expression of the 61 kDa firefly 
luciferase protein, while also inducing cell lysis. The expression of firefly luciferase 
becomes stable after ten minutes and remains relatively stable for two hours (Promega, 
2013). The second substrate, the Dual-Glo® Stop and Glo® Substrate, is then added with 
the Dual-Glo® Stop and Glo® Buffer to quench firefly luminescence 10,000-fold and 
generate the expression of the 36 kDa Renilla luciferase protein. The luminescence of 
Renilla luciferase becomes stable after ten minutes and remains relatively stable for two 
hours as well (Promega, 2013).  
 In order to test which portion of the NCOA7-AS promoter region is necessary for 
induction by INF, three inserts containing different sized portions of the upstream 
promoter sequence of NCOA7-AS were ligated into the promoter region of a Renilla 
luciferase plasmid which is co-transfected into mammalian cells along with a firefly 
luciferase plasmid so that expression can be normalized. Once transfected, cells will be 
treated with interferon to test if the promoter is induced resulting in increased Renilla 
luciferase luminescence. There are several different plasmids that are used within the 
experiment to create experimental conditions and ensure the assay is working accurately.  
   
PhRLnull 
 The phRLnull control plasmid is a 3320 base pair plasmid which contains a 
polyclonal site upstream of the start site of its Renilla luciferase gene as well as an 
ampicillin resistance gene. The phRLnull plasmid contains no promoter or enhancer 
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elements of its own and is designed to allow for regulatory elements to be cloned into the 
plasmid in order to drive expression of the luciferase protein (Promega, 2012). In this 
experiment phRLnull is used as the vector which contains each of the inserts. Its native, 
promoter-less, form is used as a negative control for the assay.   
 
PhRL-TK 
 The phRL-TK plasmid is a 4045 base pair plasmid that contains an ampicillin 
resistance gene as well as a herpes simplex virus thymidine kinase (HSV-TK) promoter 
for its Renilla luciferase gene. This promoter creates low to moderate luciferase 
expression in the assay (Promega, 2012). PhRL-TK transfected cells are used as a 
positive control. A greater luminescence in these cells than the control phRLnull plasmid 
transfected cells shows that the transfection has worked, and that the presence of the 
promoter results in increased Renilla luciferase activity.  
 
PGL3 
The pGL3 control vector is a firefly (Photinus pyralis) luciferase containing 
plasmid that uses a SV40 promoter to activate gene expression (Promega, 2012). Within 
the experiment pGL3 is co-transfected with each experimental plasmid to create firefly 
luciferase activity and to serve as a measure of transfection efficiency. Firefly luciferase 
luminescence acts as a marker of transfection and allows the ratio of each luciferase 
luminescence to be normalized for each well in the 96-well plate.  
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PROJECT PURPOSE 
 
 As discussed in the Background, INFβ-1b interaction with the NCOA7-AS 
promoter region induces the transcription of the NCOA7-AS gene. However it is currently 
unknown how much of the promoter region is necessary for the maximal amount of 
transcription induction by INFβ-1b. The primary purpose of this project is to make use of 
the Dual-Glo® Luciferase Assay System to determine how much of the upstream portion 
of the NCOA7-AS promoter region is necessary in order to interact with INFβ-1b to 
produce the NCOA7-AS protein. The narrowing down of the necessary region will allow 
later experiments to use directed mutagenesis to determine how mutations in various 
regions affect NCOA7-AS production.   
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METHODS 
 
E. coli Strains, Plasmids, and Primers 
 
Strain Number Cell Type and Plasmid Inserted 
MV 7051 Q cells + pGL3 vector 
MV 7052 Q cells + pGL3 vector 
MV 7053 Q cells + phRL-TK vector 
MV 7054 Q cells + phRL-TK vector 
MV 7055 Q cells + phRLnull vector 
MV 7056 Q cells + phRLnull vector 
MV 7057 DH5α + pMV 1562 
MV 7058 DH5α + pMV 1563 
MV 7059 DH5α + pMV 1564 
MV 7060 DH5α + pMV 1565 
MV 7061 DH5α + pMV 1566 
MV 7062 DH5α + pMV 1567 
MV 7063 DH5α + pMV 1568 
MV 7064 DH5α + pMV 1569 
MV 7065 DH5α + pMV 1570 
MV 7066 DH5α + pMV 1571 
MV 7067 DH5α + pMV 1572 
MV 7068 DH5α + pMV 1573 
Table 1: Table of Cell Lines used in this Experiment 
 
Plasmid 
Name 
Vector Insert  Mutation 
pMV 1562 pRLnull vector, AMP
r 
568 bp NCOA7-AS 
promoter region insert.  
Deletion of A 
within insert at 
plasmid base pair 
275. 
pMV 1563 pRLnull vector, AMP
r
 568 bp NCOA7-AS 
promoter region insert.  
No mutations 
pMV 1564 pRLnull vector, AMP
r
 568 bp NCOA7-AS 
promoter region insert.  
A-C transversion at 
plasmid base pair 
277, A-G transition 
at bp 278, and G-A 
transition 344. 
pMV 1565 pRLnull vector, AMP
r
 568 bp NCOA7-AS 
promoter region insert 
T-C transition at 
plasmid base pair 
38 and G-A 
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transition at bp 
521. 
pMV 1566 pRLnull vector, AMP
r
 133 bp NCOA7-AS 
promoter region insert.  
 A-G transition 
within insert at 
plasmid base pair 
96. 
pMV 1567 pRLnull vector, AMP
r
 133 bp NCOA7-AS 
promoter region insert.  
Inserted sequence 
not shown on 
chromatogram. 
Mutation status 
unknown. 
pMV 1568 pRLnull vector, AMP
r
 133 bp NCOA7-AS 
promoter region insert. 
No mutations 
pMV 1569 pRLnull vector, AMP
r
 133 bp NCOA7-AS 
promoter region insert.  
No mutations 
pMV 1570 pRLnull vector, AMP
r
 54 bp NCOA7-AS 
promoter region insert 
No mutation 
pMV 1571 pRLnull vector, AMP
r
 54 bp NCOA7-AS 
promoter region insert 
Sequencing was 
only successful in 
one direction. 
Mutation status 
unknown. 
pMV 1572 pRLnull vector, AMP
r
 54 bp NCOA7-AS 
promoter region insert 
No mutation 
pMV 1573 pRLnull vector, AMP
r
 54 bp NCOA7-AS 
promoter region insert 
No mutation 
Table 2: Table of Plasmids Created in this Experiment 
 
Primer 
Number 
Primer 
Name 
Sequence (5’-3’) Use 
651 NCOA7
AS-up 
 
GCGCCTCGAGGCCTGGCAGGAAG
TGTGTTTGC 
Created 133 bp insert with 
both primers 652 and 659. 
Contains Xho1 restriction site. 
652 NCOA7
A-Sdn 
 
CGCGGGCGCCCTGTTTTCTCAGTA
TCTAGTTTCC 
Created 133 bp insert. 
Contains Nar1 restriction site. 
Replaced by primer 659. 
653 AS-TOP TCGATTCTCAGGGAAACAGAAAC
AGAAACTCAATCATGCAGGAAAC
TAGATACTGAG 
Oligonucleotide sequences 
were annealed together to 
create 54 base pair insert. 
654 AS-BOT  
CTAGCTCAGTATCTAGTTTCCTGC
ATGATTGAGTTTCTGTTTCCCTCA
GGAGAA 
655 pRLinser
t-F 
 
CATGCAGGAAACTAGATACTG 
Tested plasmids for insert 
ligation through PCR. 
656 pRLinser  
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t-Rev CAATAAGGTCTGGTATAATACAC
CGC 
657 657 GCGCCTCGAGTATAAAACTACAT
GTAAGATGAC 
Created 568 bp insert 
658 658 GCGCACTAGTCTGTTTTCTCAGTA
TCTAGTTTCC 
659 Pncoa7  
CGCGACTAGTCTGTTTTCTCAGTA
TCTAGTTTCC 
Replaced primer 652 to create 
133 bp insert. Contains Spe1 
restriction site. 
660 pRLseqf GCCTTTTTACGGTTCCTGGCC Sequencing primers 
661 pRLseqR GTAACCTTGATACTTACCTGC 
Table 3: Table of Primers Used in This Experiment 
 
General Processes 
 Purification of plasmids 
 All plasmids were purified from E. coli cells grown overnight in a culture of LB+ 
Ampicillin (AMP) broth. These cells were pelleted in a centrifuge and then the plasmids 
were extracted using Qiagen’s QIAprep Spin miniprep kit.  
 
Calculation of Cellular DNA Concentration 
  Concentration of DNA was calculated using the Nanodrop 1000 
spectrophotometer using nanodrop software. After blanking the machine with 10% 
Elution buffer, 1.5-2µl of each sample was loaded onto the machine. Concentration data 
for each sample was then reported in ng/µl.  
 
Creation of Inserts 
 Three inserts, each containing the STAT, IRSE, and INF sites, as well as different 
amounts of the upstream region of the NCOA7-AS promoter region, were created in 
order to learn what size of the upstream promoter region was necessary for the induction 
of NCOA7-AS by interferonβ-1b (See Figure 6).  The 568 and 133 base pair inserts were 
 22 
created through the use of a PCR reaction while the 54 base pair insert was developed 
using annealing two oligonucleotide sequences in a thermocycler.  
 
Figure 6: Pictorial Representation of PCR-Generated Inserts. Location of the STAT, ISRE, 
and IRF sequences on each insert are Indicated by boxes. Sequence A is 568 bp long, Sequence B 
is 133 bp long, and Sequence C is 54 bp long. 
 
 
PCR Insert Creation 
The 596 insert was developed by performing PCR reaction with primers 657 
(GCGCCTCGAGTATAAAACTACATGTAAGATGAC) and 658 
(GCGCACTAGTCTGTTTTCTCAGTATCTAGTTTCC) to create a product which 
contained the suspected promoter boxes of NOA7-AS as well as about 500 base pairs of 
the region’s upstream sequence (see Figure 6A). The PCR product was purified using 
Qiagen’s QIAquick PCR purification kit and analyzed by gel electrophoresis to 
determine if correct product was formed. 
 The 133 base pair insert was created and analyzed in the same process as the 596 
base pair insert using primers 651 
(GCGCCTCGAGGCCTGGCAGGAAGTGTGTTTGC) and 659 
(CGCGACTAGTCTGTTTTCTCAGTATCTAGTTTCC) creating a product containing 
the suspected promoter region along with around 75 base pairs of the surrounding 
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sequence. Originally primer 652 
(CGCGGGCGCCCTGTTTTCTCAGTATCTAGTTTCC) was used to generate the insert 
along with primer 651. This primer was replaced as it contains a Nar1 restriction site 
which was determined to be inefficient in cutting the phRLnull vector.  
 
Restriction Digest of PhRLnull and Inserts 
 Both PCR product inserts contain an upstream Xho1 and a downstream Spe1 
restriction site which correspond to the same sites within the polycloning domain of the 
phRLnull plasmid. To prepare the inserts and plasmids for ligation, inserts and plasmids 
were digested with Xho1 and Spe1 in New England Biolabs’ reaction buffer 4 and 0.1 
mg/ml BSA for two hours at 37ºC. At an hour and a half 4µl of the plasmid digestion was 
run through gel electrophoresis to determine if the complete digestion was achieved. If 
digestion was not seen an additional sample was run every half hour until digestion was 
achieved. When digestion was achieved the enzymes were heat inactivated by incubation 
in a 65ºC water bath for twenty minutes. Samples were then purified using the Qiagen’s 
QIAquick PCR purification kit to remove unwanted segments.    
 
Plasmid Dephosphorylation 
  A portion of the digested plasmids had their 5’ sticky ends dephosphorylated 
using Antarctic Phosphatase to prevent the plasmid from re-annealing on itself to increase 
ligation efficiency. 1/10 volume of 10x Antarctic Phosphatase buffer was mixed with 
digested plasmids and then 1µl Antarctic phosphatase was mixed into the solution. Cells 
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were incubated at 37ºC for 15 minutes and then the enzyme was heat inactivated at 65ºC 
for 5 minutes.  
 
Annealing of 54 base pair insert  
 The 54 base pair insert was created by annealing the two oligonucleotides, 
primers 657 (GCGCCTCGAGTATAAAACTACATGTAAGATGAC) and 658 
(GCGCACTAGTCTGTTTTCTCAGTATCTAGTTTCC) together in the thermocycler 
using a preset program that heated the DNA to 90°C for 1 min then dropping 
0.1°C/second until it reaches 4°C, then held at 4°C until the DNA was removed. The 
annealed 54 bp oligonucleotide insert contains the predicted promoter region only with 
no additional surrounding sequences. The ends of the insert contain the sticky end 
sequences for the Xho1 and Spe1 to allow for ligation of the insert to the cut phRLnull 
plasmid. 
 
DNA Ligations  
 Both insert digests were ligated with dephosphorylated digested plasmids using 
New England Biolab’s Quick Ligase kit. The 54 base pair annealed oligonucleotide insert 
was ligated to digested plasmids that were not dephosphorylated as the 5’ phosphate was 
necessary. The digests were ligated at room temperature for 5 minutes and then stored on 
ice.   
Generation of Experimental Plasmids and Cell Lines 
 With the inserts ligated into plasmids, transformations were performed to create 
stable E. coli cell lines containing each insert.  
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Making Competent Cells  
DH5α E. coli cells were made competent for transformation in Dr. Volkert’s lab 
through use of the Inoue method of creating competent cells. Cells were grown overnight 
in LB media and diluted 1:20 LB media. Cells were grown to have A600 of about 0.7 and 
placed on ice. Cells were then spun at 2000g for 10 minutes at 4ºC and the pellet was 
resuspended in 16 ml 4ºC transformation buffer. Cells were spun at 2000g for ten minutes 
at 4ºC once again and the pellet was resuspended in 4ml of 4ºC transformation buffer 
with 0.3ml sterile DMSO. Cells were then incubated on ice for ten minutes and then the 
cell suspension was separated into 100µl aliquots. Aliquots were then flash frozen in 
liquid nitrogen and stored at -80ºC until ready for use.  
 
Transformation of Ligated Plasmids 
 When used competent cells were thawed on ice for thirty minutes and mixed with 
either no DNA or 5µl product of a ligation reaction. Cells were allowed to incubate on ice 
for thirty minutes and were then heat shocked at 42ºC for thirty seconds. Cells were 
returned to the ice bath for two minutes and then were suspended in 250µl of LB medium 
and were placed in 37ºC rotating incubator for one hour. Cells were then plated on LB+ 
AMP plates and incubated overnight at 37ºC. 
 
Plasmid Identification 
In the morning plates were examined for positive transformants. If growth on 
experimental plates was greater than control, single colonies were selected from 
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experimental plates and used to inoculate culture tubes of LB+ AMP broth which were 
incubated overnight at 37ºC. Remaining cell suspension was used to streak for single 
colonies on LB+AMP plates.  
Plasmids were purified from cell suspension using Qiagen’s QIAprep Spin 
miniprep kit and were tested presence of the insert using three different methods. First 
each plasmid was tested for the presence of a specifically sized PCR products using 
primers 655 (CATGCAGGAAACTAGATACTG) and 656 
(CAATAAGGTCTGGTATAATACACCGC).  
The second method was to test for inclusion of the insert by restriction digestion. 
Digestions of plasmids with 568 base pair insert were carried out as before with Spe1 and 
Xho1. The other two inserts were digested with Bsu361 and Bgl1 and New England 
Biolabs’ reaction buffer 3 and 0.1 mg/ml BSA for two hours at 37ºC. The restriction 
enzymes were then heat inactivated for twenty minutes at 65ºC.  
Finally plasmids which showed appropriate cutting patterns were sent to 
Sequegen with primers 660 (GCCTTTTTACGGTTCCTGGCC) and 661 
(GTAACCTTGATACTTACCTGC) and the resulting chromatograms were analyzed 
using Finch T.V. and a BLAST alignment search to compare the expected sequence of 
the phRLnull plasmid with the sequence obtained from each insert. Plasmids containing 
inserts lacking mutations were selected for use in the luciferase assays.  
 Plasmids that were sent for sequencing were given a plasmid number. The cell 
strain from which each plasmid was derived was selected from the single colony 
streaking plate and grown overnight at 37ºC in LB+AMP broth. The next day the cell 
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suspensions were mixed with sterile DMSO (10% final concentration) and were stored at 
-80ºC.  
 
Determining the INF- Interacting site on the NCOA7-AS Promoter Region  
 Plasmids with mutation-free inserts were used in the Dual-Glo® luciferase assay 
to determine the amount of the upstream sequence needed for induction by Interferon β-
1b. 
 
Splitting of HT1080 cells 
 Human HT1080 fibrosarcoma cells were grown by Dr. Volkert’s lab from frozen 
stock. Once cells in culture flask reached a cell density of around 80% cell confluence, 
the cells were washed and suspended by draining the media, washing with PBS and then 
trypsinizing the cells for 5 minutes. Once trypsinized the cells were resuspended in fresh 
media, the cells were split into at least 35 wells in a 96- well plate along with a daughter 
flask and allowed to grow overnight.  
   
Transfection of Vectors 
 Six wells in the 96-well plate were co-transfected with pGL3 along with either 
pMV 1572, pMV 1568, pMV 1563, phRLTK, or phRLnull using Invitrogen’s 
Lipofectamine® 2000 reagent. 0.4µg of each plasmid was mixed with 40µl of Opti-
MEM® I Reduced Serum Media. These mixtures were mixed with 2.4µl of 
Lipofectamine in 40µl of Opti-MEM® I Media, after a five minute incubation. After a 20 
minute incubation at room temperature 10µl of each Lipofectamine mixture was added to 
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six wells on each plate in the format seen as Figure 7. After two and a half hours the 
media in each well was replaced.  
Figure 7: Experimental setup for Dual Luciferase Assay 
Interferon Treatment 
 The first three wells of each row were treated with 2µl of INF that was diluted 
from 1.32 mg/ml to 7.46x10
-5
 µg/µl in early experiments or 1.91x10
-3
 µg/µl in the final 
test after tests to determine if increased interferon concentration was needed for 
induction. Interferon was allowed to incubate at 37ºC for four hours and then assay was 
performed.    
The Dual- Glo® Luciferase Assay 
 The volume of media in each well was brought to 75µl and then each cell was 
treated with 75µl of the Dual-Glo® Luciferase substrate to induce the expression of 
firefly luciferase. After a ten minute incubation, luminescence was recorded using a ten 
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second exposure time for each well to ensure an accurate measure of luminescence. After 
firefly luminescence was recorded, the Dual-Glo® Stop and Glo® Reagent was mixed by 
diluting the Dual-Glo® Stop and Glo® Substrate in Dual-Glo® Stop and Glo® Buffer  to 
1:100 the needed volume of reagent. Once mixed 75µl of the Reagent was added to each 
well to squelch firefly luminescence and induce Renilla luciferase luminescence. After 10 
minutes Renilla luciferase luminescence was read in the plate reader with a ten second 
exposure time.   
 
Data Analysis 
 All luminescence readings were compared to non-transfected control wells to 
determine levels of background luminescence and check for possible contamination. The 
recorded Renilla luminescence from each well was divided by the firefly luminescence of 
that well to normalize the data. The mean for each type transfection ±INF treatment was 
calculated along with standard deviation.  
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RESULTS 
 
 
 
 The purpose of this project was to determine what portion of the NCOA7-AS 
promoter region was necessary for gene induction by INFβ-1b treatment using Promega’s 
Dual-Glo® Luciferase Assay. This was accomplished by creating three phRLnull plasmid 
strains that each contained the suspected NCOA7-AS promoter region sequence as well as 
varying amounts of the upstream sequence of the promoter within the plasmid’s 
luciferase promoter region. These plasmids were transfected into human HT1080 cells.  It 
was suspected that if the necessary promoter region was within the transfected cells then 
treatment of the cells with INFβ-1b would induce stronger Renilla luciferase 
luminescence than untreated cells of the same transfection.  
The three inserts were created using primers designed to test different portions of 
the upstream region of the NCOA7-AS gene. The smallest insert was designed to test only 
the suspected promoter region, the 133 bp promoter was designed to test the suspected 
promoter and the immediate upstream region, and the 568 bp promoter was designed to 
search a large upstream area to maximize the chance that the promoter region would be 
contain all the necessary regulatory sequences and show INF induction. By observing a 
response to INF in any of the promoter-luciferase fusions estimations can be made about 
how much of the region is necessary for INF induction of NCOA7-AS  and guide future 
experiments to narrow down the region and determine which elements are critical for 
function .  
The two large experimental plasmids were developed by using primers to 
generate the insert using PCR. The smallest insert was produced by synthesizing two 
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complimentary oligonucleotides containing the promoter sequence and sequences 
required for annealing to the vector’s restriction sites. Inserts were then digested with 
Spe1 and Xho1 along with the phRLnull plasmids in order to create complimentary 
sticky ends. Inserts and cut plasmids were ligated together and transformed into DH5α E. 
coli cells and grown on LB+AMP plates to see if ligation was successful. If colonies on 
the experimental plate outnumbered colonies on a control plate with no insert, colonies 
from the experimental plate were inoculated in LB+AMP broth to create a cell stock of 
each plasmid.  
Plasmids were tested for presence of insert using PCR with primers 655 
(CATGCAGGAAACTAGATACTG) and 656 
(CAATAAGGTCTGGTATAATACACCGC) to generate a 583 bp band when tested on 
the large 568 bp insert containing plasmid. None of these PCR reactions generated the 
expected product however as the internal plasmid sequence primer, primer hsdfdh, did 
not match the internal sequence of the plasmid due to an incorrect plasmid sequence 
being given to Dr. Volkert’s lab by Promega. As such four successful transformants from 
the 568 bp insert plate and were sequenced by Sequegen to find out if the insert 
successfully made it into any of the plasmids. One plasmid that was sequenced, pMV 
1563, was shown to have the expected sequence with no mutations, see Figure 8, and 
was selected to be used in the luciferase assay.  
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Figure 8: Insert Sequences of Experimental Vectors. Restriction enzyme sequences are shown 
in bold. Predicted NCOA7-AS promoter region sequence shown in capitalized sequence. 
 
The next two plasmids were checked for insert inclusion by a double digestion 
with the restriction enzymes Bgl1 and Bsu361 as the sequence given to Dr. Volkert’s lab 
suggested phRLnull had a single Bgl1 site and the addition of an insert would create a 
single Bsu361 site within the plasmid. The predicted products of these digests were 2316 
bp and 1103 bp for the 133 bp insert plasmids 2,335 bp and 1,037 bp for the 54 bp 
inserted plasmid. As the plasmid sequence which was used to generate this test was 
incorrect, additional cuts by both enzymes were found to be present present in the 
phRLnull plasmids leading to smaller bands, as seen in Figure 9. Following this result 
four of each type of plasmid were sequenced and pMV 1568 and pMV 1570 were shown 
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to have the correct, mutation free insert sequence, seen in Figure 8, and were selected to 
be used in the luciferase assay.      
Figure 9: Gel of Bsu361 and Bgl1 Digested 133 bp Inserted Plasmids. PhRLnull acts as a negative 
control and pMV 1563 shows a positive reaction. Tested plasmids in lanes 5 and 6 were determined to be 
negative for insert. All other plasmids show positive insertion of 133 bp insert.   
 
Thus PMV 1563 contains the correct 568 bp promoter, pMV 1568 contains the 
correct 133 bp promoter, and pMV 1570 contains the correct 54 bp promoter. These three 
plasmids, along with phRLnull and phRLTK, were each co-transfected with pGL3 into 
six wells of HT1080 cells grown in a 96-well plate as seen in Figure 7. Three days after 
the transfection, three wells of each transfection were treated with 2µl interferon beta at a 
concentration of 7.46x10
-5
 µg/µl and allowed to incubate for four hours. 
After the four hour incubation each well was treated first with the Dual-Glo® 
Luciferase substrate to allow firefly luciferase luminescence (encoded by pGL3) to be 
read and then treated with the Dual-Glo® Stop and Glo® Luciferase substrate to allow 
the Renilla Luciferase to be read. The Renilla luciferase luminescence reading was 
divided by the firefly luciferase luminescence reading in order to normalize the results for 
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each well to account for difference in transfection efficiency. The normalized 
luminescence was multiplied by 100. This data is shown in Table 4.  
 (+) INF (-) INF 
Well # 1 2 3 4 5 6 
phRLnull 4.04 5.51 6.25 6.9 5.36 5.5 
pMV 1563 68.49 75 89.36 62 76.92 81.25 
pMV 1568 34.88 47.54 28.89 45.76 31.91 28.89 
pMV1568 16.13 22.62 22.39 19.75 18.03 19.23 
pRLTK 7.69 12.12 10.53 11.43 8.57 9.76 
Table 4: Normalized Luciferase Assay Data. Data shown is (Renilla luciferase luminescence/ firefly 
luciferase luminescence) *100. 
 
The normalized values of each transfection ± INF treatment were averaged and 
their standard deviations were calculated for each.  This allowed each set of numbers to 
be compared to see if any cells carrying promoter-luciferase fusions showed an increase 
in Renilla luciferase luminescence when treated with INF. As Figure 10 shows, no 
increase in luciferase luminescence due to INF treatment was seen in any of the cells 
tested. However each insert acted as constitutive promoter for luciferase activity, since 
luciferase expression levels of phRL plasmids were greater than that seen with the 
promoter-less phRLnull plasmids (Figure 4).  
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Figure 10: Averaged Normalized Reponses ±INF Treatment. The average normalized ratio for each 
type of transfection ±INF treatment is shown by bar. Error bars indicate standard deviation.   
 
In order to determine if the concentration of interferon was insufficient a small 
experiment was conducted to determine if a higher concentration was needed to induce 
the promoter. Eight wells were co-transfected, four with pMV 1563 and pGL3, and four 
with phRLnull and pGL3.   After three days one well of each transfection was treated 
with the same concentration of INF used in the previous experiment (Table 4), one well 
of each plasmid bearing cell line was treated with a concentration that was ten times 
greater, one well of each cell line was treated with twenty-five times the original 
concentration, and one of each was left untreated. After four hours the luciferase assay 
 36 
was performed on the wells giving the data seen below in Table 5. The data suggested 
that increasing the INF concentration may yield an increase in promoter activity as seen 
in the doubling in signal between untreated and twenty-fives times concentrated INF 
treated pMV1563 transfected cells.  
Treatment Untreated 1x INF 10X INF 25x INF 
Well # 1 2 3 4 
phRLnull 1.42 6.02 4.82 4.42 
pMV 1563 25.71 36.36 48.72 58 
Table 5: Normalized INF Concentration Test. Data shown is (Renilla luciferase luminescence/ 
firefly luciferase luminescence) *100. 
 
A full scale experiment using interferon beta that was 1.91x10
-3
 µg/µl was 
performed in an otherwise identical way as the previous experiment to yield the 
normalized Renilla Luciferase ratios seen in Table 6.  
 (+) 25x INF (-) INF 
Well # 1 2 3 4 5 6 
phRLnull 3.57 8.33 9.08 10.25 8.16 5.357 
pMV 1563 71.43 100 94.74 93.75 88.89 93.33 
pMV 1568 56 76.19 84.21 105 100 65.38 
pMV1568 16.67 22.86 53.33 40 43.75 23.33 
pRLTK 20 27.27 30 33.33 33.33 27.27 
Table 6: Normalized Ratios for Increased Luciferase Concentration Experiment. Data shown 
is (Renilla luciferase luminescence/ firefly luciferase luminescence) *100. 
 
The values ± INF treatment were averaged as before, as seen in Figure 11, 
showing no difference between INF treated and untreated cells as before. This suggests 
that INF was unable to induce the Renilla luciferase luminescence over the levels that the 
promoter constitutively expresses, leaving the results about INF induction inconclusive. 
A notable item in this experiment was the large signal within the non-transfected cells 
which was unseen in other experiments (data not shown). This suggests that the cells had 
 37 
low transfection rates making the cells unable to bring luminescence over baseline levels, 
and may have been contaminated bringing the results of this experiment into question.  
Figure 11: Averaged Normalized Reponses ± 25x INF Treatment. The average normalized ratio for 
each type of transfection ±INF treatment is shown by bar. Error bars indicate standard deviation.   
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DISCUSSION 
 
 
 
 It is known through the experiments conducted by Yu et al. that JAK-STAT 
signaling is required for induction of NCOA7-AS by interferon beta because mutant 
derivatives of HT1080 cells with inactivating mutations JAK1, STAT2, or IFNAR2 
receptor genes lost the ability to be induced by INF. (Yu et al., submitted for publication). 
These regulatory elements are known to bind to a conserved sequence that is similar to 
the sequence found in the region present within all three of the promoters I constructed.  
 This region plus increasing upstream regions were present in the three different 
promoters. The NCOA7-AS gene is known to respond to interferon beta and shows little 
or basal level expression in the absence of IFN and a strong induction of mRNA within 
four hours of treatment with INF. As such it was expected that a similar result would 
occur in one or more of the promoters. The amount of upstream DNA necessary for this 
induction was presumed to depend on whether any less characterized JAK-STAT 
sequences were also required for induction.  
 Instead of the expected results, we found that all the promoters showed were 
essentially equally active with or without INF treatment. The IFN used in the experiment 
was deemed active, since induction of mRNA of the native gene could still be achieved in 
HT1080 cells with the same stock of IFN. Thus it appears that all promoters were 
constitutive when introduced into the luciferase plasmid, rather than inducible. This 
suggests there may be more at work in the induction of NCOA7-AS then we currently 
realize.  
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 There are a number of things that these results suggest. One possibility is that, as 
the gene is eukaryotic, the promoter may have different activity when placed into a 
plasmid. For full repression of the promoter to take effect chromatin structure and proper 
positioning of histones may be required.  Chromatin structure has been shown as 
important to a class of inducible promoters that are known to be associated with closely 
spaced nucleosomes. One well characterized promoter of this type is the promoter of the 
gene PHO5. PHO5 is a gene in yeast which encodes an acid phosphatase and which is 
induced and repressed based on the level of intercellular phosphate (Adkins & Tyler, 
2006). The induction of PHO5 causes several nucleosomes, the repeating unit of 
chromosomal DNA that is wrapped around a histone, to be dissociated from the gene’s 
promoter region. When PHO5 is repressed the nucleosome is reformed with new histones 
(Adkins & Tyler, 2006). If the histone chaperone SPT6, which mediates nucleosome 
reassembly, is mutated however, the activated PHO5 gene, along with other genes with 
this type of promoter, will be transcribed even in the absence of transcription factors 
suggesting that the histone presence is essential for gene regulation (Adkins & Tyler, 
2006; Rando & Ahmad, 2007). 
As the NCOA7-AS promoter region is not a well characterized, it is possible that 
the promoter may be associated with closely spaced nucleosomes. If this is the case, 
inserting the promoter region into a plasmid may prevent essential gene regulation by 
histones, leaving the promoter region constitutively active. This potential explanation 
should be considered  when guiding future experiments to refine the parameters in which 
the promoter region is analyzed and the experimental constructs are developed.  
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The experiment performed with the twenty-five times increased concentration of 
INF was interesting as the results in the large scale experiment did not match those of the 
small test assay performed earlier. Though this could be due to lack of multiple trials, as 
in usual testing there are fairly large standard deviations between plasmids of the same 
transfection and treatment, there is a possibility of experimental error. The evidence of 
this was that the wells of non-transfected HT1080 cells that were tested reported much 
higher levels of luminescence than previously observed in any of the previous trials. As 
these wells are assayed to show the levels of background luminescence, it is possible that 
contamination of the wells or the luciferase assay reagents occurred leading the results of 
that assay to be inconclusive. As such it is suggested that the assay be carried out again 
with new reagents and cells to determine if the concentration of INFβ-1b could induce a 
greater luminescence signal over non-treated cells.  
Another possibility to consider would be to extend the incubation times of INFβ-
1b treated cells for longer periods of time before reading the luciferase to see if there is 
an increase in luminescence in cells that were treated with INFβ-1b for a longer period of 
time. Northern blots should also be performed post assay to determine if the mRNA 
levels of luciferase have increased due to induction by INFβ-1b.     
If either of these methods of manipulating the assay do not give the expected 
increase in INF response through treatment, analysis through the use of the luciferase 
assay should be abandoned as the promoter likely is unable to retain its chromatin 
structure which may be necessary for regulation of the NCOA7-AS gene by INF. Future 
studies should find a way to recreate our promoter sequences to a reporter gene in a 
chromatin structure and treat similarly with INF to see if activation is  dependent on 
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chromatin structure, as well learning possibly learning something about why chromatin 
structure may cause such different expression patterns than plasmid circular structure.   
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